Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Sabratek

This article was originally published in The Gray Sheet

Executive Summary

Retains restructuring firm Jay Alix & Associates to develop and implement restructuring plans. Also announced are the resignations of Chairman and CEO Shan Padda and Doron Levitas, vice-chariman and secretary; both will retain their positions as directors of the company. A representative of Jay Alix will be appointed acting CEO. The firm plans to report second quarter earnings "as soon as practicable" after auditors complete a previously announced review, but Sabratek was unable to meet the Aug. 20 deadline for its Form 10-Q. The law firm of Cohen, Milstein, Hausfeld & Toll announced Aug. 25 that they have filed a lawsuit against the company in Chicago federal court on behalf of persons who purchased Sabratek's common stock between May 11 and Aug. 23, 1999
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT012244

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel